NASDAQ:TLRY

Tilray Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy TLRY

*Your capital is at risk

$5.11

-0.270 (-5.02%)

At Close: Jun 03, 2026

Tilray Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 95.63. In total, the insiders bought 45.02M and sold 3.44M TLRY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	95.63
● Buy	45.02M shares
● Sell	3.44M shares
77% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Apr 21, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 95.63. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 21, 2026 Sell	Common Stock S-Sale	Hopkinson David G. Director	Director	33 556 Value: $232.9K
Jan 07, 2026 Buy	Common Stock M-Exempt	Cohen Steven Michael Director	Director	12 438 Value: $111.8K
Jan 07, 2026 Buy	Restricted Stock Units M-Exempt	Cohen Steven Michael Director	Director	12 438 Value: $111.8K
Jul 31, 2025 Buy	Common Stock M-Exempt	Simon Irwin D President And CEO	CEO / President	706 216 Value: $409.6K
Jul 31, 2025 Sell	Common Stock F-InKind	Simon Irwin D President And CEO	CEO / President	374 295 Value: $217.1K
Jul 31, 2025 Buy	Performance-Based Restricted Stock Units ("2022 PSUs") M-Exempt	Simon Irwin D President And CEO	CEO / President	353 108 Value: $2.05M
Jul 31, 2025 Buy	Common Stock M-Exempt	Merton Carl A Chief Financial Officer	C-Suite Officer	93 928 Value: $54.5K
Jul 31, 2025 Sell	Common Stock F-InKind	Merton Carl A Chief Financial Officer	C-Suite Officer	49 782 Value: $28.9K
Jul 31, 2025 Buy	Performance-Based Restricted Stock Units ("2022 PSUs") M-Exempt	Merton Carl A Chief Financial Officer	C-Suite Officer	46 964 Value: $272.9K
Jul 31, 2025 Buy	Common Stock M-Exempt	Gendel Mitchell Global General Counsel	Officer	93 928 Value: $54.5K
Jul 31, 2025 Buy	Common Stock P-Purchase	Gendel Mitchell Global General Counsel	Officer	6 000 Value: $3K
Jul 31, 2025 Sell	Common Stock F-InKind	Gendel Mitchell Global General Counsel	Officer	49 782 Value: $28.9K
Jul 31, 2025 Buy	Performance-Based Restricted Stock Units ("2022 PSUs") M-Exempt	Gendel Mitchell Global General Counsel	Officer	46 964 Value: $272.9K
Jul 31, 2025 Buy	Common Stock M-Exempt	Faltischek Denise M Chief Strategy Officer	Officer	93 928 Value: $54.5K
Jul 31, 2025 Sell	Common Stock F-InKind	Faltischek Denise M Chief Strategy Officer	Officer	49 782 Value: $28.9K
Jul 31, 2025 Buy	Performance-Based Restricted Stock Units ("2022 PSUs") M-Exempt	Faltischek Denise M Chief Strategy Officer	Officer	46 964 Value: $272.9K
Jul 31, 2025 Buy	Performance-Based Restricted Stock Units ("2022 PSUs") M-Exempt	Faltischek Denise M Chief Strategy Officer	Officer	46 964 Value: $272.9K
Jul 31, 2025 Sell	Common Stock F-InKind	Faltischek Denise M Chief Strategy Officer	Officer	49 782 Value: $28.9K
Jul 31, 2025 Buy	Common Stock M-Exempt	Faltischek Denise M Chief Strategy Officer	Officer	93 928 Value: $54.5K
Jul 31, 2025 Buy	Performance-Based Restricted Stock Units ("2022 PSUs") M-Exempt	Gendel Mitchell Global General Counsel	Officer	46 964 Value: $272.9K
Jul 31, 2025 Sell	Common Stock F-InKind	Gendel Mitchell Global General Counsel	Officer	49 782 Value: $28.9K
Jul 31, 2025 Buy	Common Stock P-Purchase	Gendel Mitchell Global General Counsel	Officer	6 000 Value: $3K
Jul 31, 2025 Buy	Common Stock M-Exempt	Gendel Mitchell Global General Counsel	Officer	93 928 Value: $54.5K
Jul 31, 2025 Buy	Performance-Based Restricted Stock Units ("2022 PSUs") M-Exempt	Merton Carl A Chief Financial Officer	C-Suite Officer	46 964 Value: $272.9K
Jul 31, 2025 Sell	Common Stock F-InKind	Merton Carl A Chief Financial Officer	C-Suite Officer	49 782 Value: $28.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT TILRAY INC.

Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness pr...

Read Full Profile Here